英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
envanir查看　envanir　在百度字典中的解释百度英翻中〔查看〕
envanir查看　envanir　在Google字典中的解释Google英翻中〔查看〕
envanir查看　envanir　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Libtayo: Uses, Side Effects, Warnings - Drugs. com
    Libtayo (cemiplimab-rwlc) is used to treat metastatic cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer Includes Libtayo side effects, interactions and indications
  • LIBTAYO® (cemiplimab-rwlc) in Advanced NSCLC, BCC, CSCC . . .
    LIBTAYO is a prescription medicine used to treat adults with a type of skin cancer called basal cell carcinoma (BCC) when your BCC cannot be removed by surgery (locally advanced BCC) or when it has spread (metastatic BCC) and have previously received treatment with a hedgehog pathway inhibitor (HHI), or cannot receive treatment with a HHI
  • Libtayo: Side Effects, Uses, Cost, Dosage, and More - Healthline
    Learn about side effects, uses, and more for Libtayo (cemiplimab-rwlc), which is a prescription drug that treats certain kinds of skin and lung cancer in adults
  • LIBTAYO® (cemiplimab-rwlc) | Adjuvant Treatment of High-Risk CSCC
    LIBTAYO® (cemiplimab-rwlc) is indicated for the adjuvant treatment of adult patients with CSCC at high risk of recurrence after surgery and radiation Review Important Safety Information and full Prescribing Information
  • Libtayo Side Effects: What They Are and How to Manage Them
    Libtayo is a prescription drug used to treat certain kinds of skin cancer and lung cancer Learn about the side effects it can cause and how to manage them
  • Treating Squamous Cell Carcinoma | Squamous Cell Cancer . . .
    Treating Squamous Cell Carcinoma of the Skin Treatment options for squamous cell cancer (SCC) of the skin depend on the risk of the cancer coming back, which is based on factors like the size and location of the tumor and how the cancer cells look under a microscope, as well as if a person has a weakened immune system
  • Libtayo (Cemiplimab-rwlc Injection): Side Effects, Uses . . .
    Drug Summary What Is Libtayo? Libtayo (cemiplimab -rwlc) is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or curative radiation What Are Side Effects of Libtayo?
  • What is LIBTAYO® (cemiplimab-rwlc) | Advanced CSCC
    LIBTAYO is the first medicine approved by the Food and Drug Administration (FDA) to treat CSCC that has spread or cannot be cured by surgery or radiation LIBTAYO is a type of immunotherapy called a programmed death receptor-1 (PD-1) inhibitor LIBTAYO is not chemotherapy or radiation therapy LIBTAYO may be right for adults with a type of skin cancer called cutaneous squamous cell carcinoma
  • FDA Approves Libtayo for Cutaneous Squamous Cell Carcinoma . . .
    Libtayo, as explained by the National Cancer Institute on its website, is a drug that binds to the protein PD-1 to help immune cells kill cancer cells better It is used to treat certain types of basal cell carcinoma and cutaneous squamous cell carcinoma, which are types of skin cancer, that are locally advanced or have spread to other parts of
  • LIBTAYO (cemiplimab-rwlc) Label - Food and Drug Administration
    LIBTAYO is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or curative radiation (1)





中文字典-英文字典  2005-2009